447 related articles for article (PubMed ID: 8989951)
21. [Intratympanic gentamicin treatment for intractable Menière's disease].
Gilony D; Wolf M; Kronenberg J
Harefuah; 2004 Jan; 143(1):4-7, 88. PubMed ID: 14748278
[TBL] [Abstract][Full Text] [Related]
22. Intratympanic gentamicin instillation as treatment of unilateral Menière's disease: update of an ongoing study.
Nedzelski JM; Chiong CM; Fradet G; Schessel DA; Bryce GE; Pfleiderer AG
Am J Otol; 1993 May; 14(3):278-82. PubMed ID: 8372926
[TBL] [Abstract][Full Text] [Related]
23. [Intratympanic treatment in Meniere's disease: the effect of gentamicin and dexamethasone on vertigo control and hearing].
Akkuzu B; Ozgirgin N; Ozlüoğlu LN
Kulak Burun Bogaz Ihtis Derg; 2006; 16(5):193-9. PubMed ID: 17124437
[TBL] [Abstract][Full Text] [Related]
24. Intratympanic gentamicin for Menière's disease: a meta-analysis.
Cohen-Kerem R; Kisilevsky V; Einarson TR; Kozer E; Koren G; Rutka JA
Laryngoscope; 2004 Dec; 114(12):2085-91. PubMed ID: 15564826
[TBL] [Abstract][Full Text] [Related]
25. [Intratympanic gentamicin in Menière's disease].
Huang W; Xu H; Gao B
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Jan; 18(1):14-6. PubMed ID: 15088342
[TBL] [Abstract][Full Text] [Related]
26. Intratympanic steroid injections for intractable Ménière's disease.
Barrs DM; Keyser JS; Stallworth C; McElveen JT
Laryngoscope; 2001 Dec; 111(12):2100-4. PubMed ID: 11802004
[TBL] [Abstract][Full Text] [Related]
27. Intentional ablation of vestibular function using commercially available topical gentamicin-betamethasone eardrops in patients with Meniere's disease: further evidence for topical eardrop ototoxicity.
Kaplan DM; Hehar SS; Bance ML; Rutka JA
Laryngoscope; 2002 Apr; 112(4):689-95. PubMed ID: 12150525
[TBL] [Abstract][Full Text] [Related]
28. Treatment of Ménière's disease with "on-demand" intratympanic gentamicin injections.
Manrique-Huarte R; Guillén-Grima F; Perez-Fernandez N
Otol Neurotol; 2011 Apr; 32(3):461-5. PubMed ID: 21317673
[TBL] [Abstract][Full Text] [Related]
29. Vestibular nerve section versus intratympanic gentamicin for Meniere's disease.
Hillman TA; Chen DA; Arriaga MA
Laryngoscope; 2004 Feb; 114(2):216-22. PubMed ID: 14755193
[TBL] [Abstract][Full Text] [Related]
30. Intratympanic gentamicin therapy for Menière's disease: preliminary comparison of two regimens.
Toth AA; Parnes LS
J Otolaryngol; 1995 Dec; 24(6):340-4. PubMed ID: 8699599
[TBL] [Abstract][Full Text] [Related]
31. Treatment of Ménière's disease by intratympanic gentamicin application.
Assimakopoulos D; Patrikakos G
J Laryngol Otol; 2003 Jan; 117(1):10-6. PubMed ID: 12590850
[TBL] [Abstract][Full Text] [Related]
32. Intratympanic gentamicin: a 1-day protocol treatment for unilateral Meniere's disease.
De Stefano A; Dispenza F; De Donato G; Caruso A; Taibah A; Sanna M
Am J Otolaryngol; 2007; 28(5):289-93. PubMed ID: 17826528
[TBL] [Abstract][Full Text] [Related]
33. Results of electrocochleography in Ménière's disease after successful vertigo control by single intratympanic gentamicin injection.
Büki B; Platz M; Haslwanter T; Jünger H; Avan P
Audiol Neurootol; 2011; 16(1):49-54. PubMed ID: 20523039
[TBL] [Abstract][Full Text] [Related]
34. Intratympanic gentamicin therapy for control of vertigo in unilateral Menire's disease: a prospective, double-blind, randomized, placebo-controlled trial.
Postema RJ; Kingma CM; Wit HP; Albers FW; Van Der Laan BF
Acta Otolaryngol; 2008 Aug; 128(8):876-80. PubMed ID: 18607963
[TBL] [Abstract][Full Text] [Related]
35. Transtympanic gentamicin treatment in Meniere's disease: a preliminary report.
Kasemsuwan L; Jariengprasert C; Chaturapatranont S
J Med Assoc Thai; 2006 Jul; 89(7):979-85. PubMed ID: 16881430
[TBL] [Abstract][Full Text] [Related]
36. Intratympanic gentamicin for the treatment of Meniere's disease and other forms of peripheral vertigo.
Carey J
Otolaryngol Clin North Am; 2004 Oct; 37(5):1075-90. PubMed ID: 15474112
[TBL] [Abstract][Full Text] [Related]
37. Intratympanic gentamicin therapy for vertigo in nonserviceable ears.
Bauer PW; MacDonald CB; Cox LC
Am J Otolaryngol; 2001; 22(2):111-5. PubMed ID: 11283825
[TBL] [Abstract][Full Text] [Related]
38. Disability in patients with Menière's disease following the use of two different treatment modalities: betahistine and intratympanic gentamicin.
Enrique-Gonzaleza A; Sánchez-Ferrándiz N; Pérez-Fernández N
Rev Laryngol Otol Rhinol (Bord); 2008; 129(4-5):249-54. PubMed ID: 19408504
[TBL] [Abstract][Full Text] [Related]
39. [The long-term results of treatment of Ménière's disease with intratympanic injections of gentamicin].
Gawęcki W; Szyfter W; Lączkowska-Przybylska J; Szyfter-Harris J
Otolaryngol Pol; 2012; 66(1):20-6. PubMed ID: 22381010
[TBL] [Abstract][Full Text] [Related]
40. Effects of a single intratympanic gentamicin injection on Meniere's disease.
Chung WH; Chung KW; Kim JH; Cho YS; Hong SH
Acta Otolaryngol Suppl; 2007 Oct; (558):61-6. PubMed ID: 17882572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
